July 28, 2024
Reference intervals for putative biomarkers of drug-induced liver injury and liver re...
Andrea Jorgensen, Samantha Korver, Amy Schofield, et al.
March 08, 2022
T CELL-MEDIATED HYPERSENSITIVITY TO LUMACAFTOR AND IVACAFTOR IN CYSTIC FIBROSIS
Aida Semic-Jusufagic, Monday Ogese, Christopher Edwards, et al.
November 22, 2021
Similarity and Consistency Assessment of Three Major Online Drug-Drug Interaction Res...
Elpida Kontsioti, Simon Maskell, Amina Bensalem, et al.
February 08, 2022
Cardiovascular drugs and COVID-19 clinical outcomes: a systematic review and meta-ana...
Innocent Asiimwe, Sudeep Pushpakom, Richard Turner, et al.
February 28, 2021
Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and m...
Innocent Asiimwe, Sudeep Pushpakon, Richard Turner, et al.
November 09, 2020
Anticoagulation in sub-Saharan Africa: Are Direct Oral Anticoagulants the answer? A r...
Jerome Semakula, Geraldine Kisa, Johannes Mouton, et al.
July 29, 2020
Improving anticoagulation in sub-Saharan Africa -- what are the challenges, and how c...
Johannes Mouton, Marc Blockman, Christine Sekaggya-Wiltshire, et al.
June 15, 2020
Safety perspectives on presently considered drugs for the treatment of COVID-19
Sophie Penman, Robyn Kiy, Rebecca Jensen, et al.